Literature DB >> 9241305

Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.

P G Crosignani1, P Vercellini, P Mosconi, S Oldani, I Cortesi, O De Giorgi.   

Abstract

OBJECTIVE: To compare the effect of a levonorgestrel-releasing intrauterine device with that of endometrial resection on menstrual bleeding, patient satisfaction, and quality of life in menorrhagic women during 12 months of follow-up.
METHODS: Seventy premenopausal women with dysfunctional uterine bleeding were enrolled in a prospective, open, parallel-group, controlled trial. They were randomized to either insertion of an intrauterine system releasing 20 micrograms/day of levonorgestrel (n = 35) or endometrial resection (n = 35). The women were evaluated at baseline, and thereafter, uterine bleeding was assessed monthly with a pictorial blood loss assessment chart. Clinical gynecologic examination was performed bimonthly, and the hematologic variables were measured at 6 and 12 months. On the latter occasion, the women were requested to rate the degree of satisfaction with the effect of their treatment and to complete the Short Form 36 General Health Survey questionnaire.
RESULTS: Recurrent menorrhagia was observed at 12 months in four women in the intrauterine device group (including two with partial expulsion of the device) and in three women in the resection group. Compared with baseline values, at 1 year, the pictorial blood loss assessment chart score was reduced by 79% in the former group and by 89% in the latter. Amenorrhea or hypomenorrhea at 12 months was reported by 65% of the women with an intrauterine device compared with 71% who underwent endometrial resection. The degree of satisfaction with treatment was high in both groups, with 29 of 34 (85%) women being satisfied or very satisfied in the intrauterine device group versus 33 of 35 (94%) in the resection group. Health-related quality of life perception was not significantly different in the two treatment groups.
CONCLUSION: Somewhat less satisfactory results were obtained with a levonorgestrel-releasing intrauterine system compared with endometrial resection for dysfunctional uterine bleeding at 1 year of follow-up.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241305     DOI: 10.1016/S0029-7844(97)00226-3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  23 in total

Review 1.  Fortnightly review. Medical management of menorrhagia.

Authors:  A Prentice
Journal:  BMJ       Date:  1999-11-20

Review 2.  Recent advances. Gynaecology.

Authors:  C Kelleher; P Braude
Journal:  BMJ       Date:  1999-09-11

Review 3.  Recent developments in hormonal contraception.

Authors:  Eleanor A Drey; Philip D Darney
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 4.  The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.

Authors:  Andrew M Kaunitz; Pirjo Inki
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

5.  Medical management of menorrhagia.

Authors:  A Prentice
Journal:  West J Med       Date:  2000-04

6.  Randomised controlled trial exists of levonorgestrel intrauterine system for menorrhagia.

Authors:  A Ikomi; N Gupta
Journal:  BMJ       Date:  1998-10-31

Review 7.  Choosing non-oral, long-acting reversible contraception.

Authors:  Mary Stewart; Deborah Bateson
Journal:  Aust Prescr       Date:  2016-10-01

Review 8.  Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.

Authors:  L J Middleton; R Champaneria; J P Daniels; S Bhattacharya; K G Cooper; N H Hilken; P O'Donovan; M Gannon; R Gray; K S Khan; J Abbott; J Barrington; S Bhattacharya; M Y Bongers; J-L Brun; R Busfield; M Sowter; T J Clark; J Cooper; K G Cooper; S L Corson; K Dickersin; N Dwyer; M Gannon; J Hawe; R Hurskainen; W R Meyer; H O'Connor; S Pinion; A M Sambrook; W H Tam; I A A van Zon-Rabelink; E Zupi
Journal:  BMJ       Date:  2010-08-16

Review 9.  Benefits and risks of pharmacological agents used for the treatment of menorrhagia.

Authors:  Samendra Nath Roy; Siladitya Bhattacharya
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

10.  Endometrial cancer after endometrial ablation vs medical management of abnormal uterine bleeding.

Authors:  Robert L Dood; Clarisa R Gracia; Mary D Sammel; Kevin Haynes; Suneeta Senapati; Brian L Strom
Journal:  J Minim Invasive Gynecol       Date:  2014-02-28       Impact factor: 4.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.